Year;Id;Title;URL;Area_WOS;N_Areas_WOS;Primary_outcome;Treatment_1;Treatment_2;Intervention_type;Outcome_type;Condition_type;Measurement_type;Improvement;Groups;base_cases_T1;base_cases_T2;base_sd_T1;base_sd_T2;final_cases_T1;final_cases_T2;final_sd_T1;final_sd_T2;change_sd_T1;change_sd_T2;rho;pvalue;pvalue_exact;significant
2004;6;Plant sterols and endurance training combine to favorably alter plasma lipid profiles in previously sedentary hypercholesterolemic adults after 8 wk;http://www.ncbi.nlm.nih.gov/pubmed/15531661;Nutrition & Dietetics;1;Plasma total cholesterol;Combination of sterols and exercise;Placebo;Pharmacological;Measured;Acute;Automatic;Down;4;18;20;1.4;1.21;18;20;1.32;1.12;0.41;0.25;0.966;NA;NA;No
2004;10;Surgical Removal vs Observation for Subfoveal Choroidal Neovascularization, Either Associated With the Ocular Histoplasmosis Syndrome or Idiopathic;http://www.ncbi.nlm.nih.gov/pubmed/15534122;Ophthalmology;1;SF-36 Mental Component;Surgery;Observation;Non-Pharmacological;Scored;Chronic;Assessed;Up;2;112;113;11.6;12;97;94;10.4;10.7;NA;NA;NA;0.4;Exact;No
2004;20;Results of Mujeres Felices por ser Saludables: a dietary/breast health randomized clinical trial for Latino women;http://www.ncbi.nlm.nih.gov/pubmed/15454356;Psychology;1;Breast self-examination proficiency;Multicomponent education program;Mailed health education;Non-Pharmacological;Scored;None;Assessed;Up;2;95;103;2.1;2.1;95;103;2.6;2;NA;NA;NA;0.001;Less than;Yes
2004;25;Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial;http://www.ncbi.nlm.nih.gov/pubmed/15367192;Dentistry, Oral Surgery & Medicine;1;Gingival index;Essential oil mouthrinse (Listerine antiseptic);Hydroalcohol negative control;Pharmacological;Scored;Acute;Assessed;Down;3;34;38;0.23;0.18;34;37;0.17;0.18;NA;NA;NA;0.001;Less than;Yes
2004;27;Guided tissue regeneration in intrabony periodontal defects following treatment with two bioabsorbable membranes in combination with bovine bone mineral graft. A clinical and radiographic study;http://www.ncbi.nlm.nih.gov/pubmed/15367197;Dentistry, Oral Surgery & Medicine;1;Clinical attachment level;Graft with collagen membrane;Access flap procedure;Non-Pharmacological;Measured;Acute;Assessed;Up;3;14;12;1.77;0.97;14;12;1.71;0.94;2.25;0.61;0.316;0.01;Exact;Yes
2004;29;Management of mandibular third molar extraction sites to prevent periodontal defects;http://www.ncbi.nlm.nih.gov/pubmed/15452808;Dentistry, Oral Surgery & Medicine;1;Clinical attachment level;Deminarizd bone powder;Guided-tissue regeneration theraphy;Non-Pharmacological;Measured;Acute;Assessed;Up;2;12;12;3.3;2.3;12;12;1.5;1.4;3.5;2.9;0.362;0.004;Exact;Yes
2004;34;Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention;http://www.ncbi.nlm.nih.gov/pubmed/15321804;Nutrition & Dietetics;1;Plasma total homocyseine;Folic acid + vitamin B12 + vitamin B6;Placebo;Non-Pharmacological;Measured;Chronic;Automatic;Down;4;22;24;6.57;6.86;21;22;3.78;8.09;NA;NA;NA;NA;NA;Yes
2004;43;A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Chinese Herbal Medicine “Ba Wei Di Huang Wan” in the Treatment of Dementia;http://www.ncbi.nlm.nih.gov/pubmed/15341554;Geriatrics & Gerontology;1;Pulsatility Index;Ba wei di huang wan (herbal medicine);Placebo;Non-Pharmacological;Measured;Chronic;Automatic;Down;2;16;17;1.7;2.2;16;17;0.5;1.3;NA;NA;NA;NA;NA;Yes
2004;46;A clinical comparison of an oscillating/rotating powered toothbrush and a manual toothbrush in patients with chronic periodontitis;http://www.ncbi.nlm.nih.gov/pubmed/15312105;Dentistry, Oral Surgery & Medicine;1;Plaque Index;Oscillating/rotating toothbrush;Manual toothbrush;Non-Pharmacological;Scored;Chronic;Assessed;Down;2;16;16;0.4;0.5;16;16;0.5;0.5;NA;NA;NA;NA;NA;No
2004;49;A randomized, controlled study of insulin pump therapy in diabetic preschoolers;http://www.ncbi.nlm.nih.gov/pubmed/15343195;Pediatrics;1;HbA1c;Continuos subcutaneous insulin infusion;Intensive insulin injection therapy;Pharmacological;Measured;Chronic;Automatic;Down;2;21;20;0.6;0.6;17;20;0.6;0.7;NA;NA;NA;NA;NA;No
2004;54;Passive Versus Active Stretching of Hip Flexor Muscles in Subjects With Limited Hip Extension: A Randomized Clinical Trial;http://www.ncbi.nlm.nih.gov/pubmed/15330693;Orthopedics$ Rehabilitation;1;Range of motion;Active Stretching;Passive Stretching;Non-Pharmacological;Measured;Acute;Automatic;Up;2;23;22;16;4;15;18;9;4;NA;NA;NA;0.21;Exact;No
2004;60;Quality of Life After Coronary Artery Bypass Graft*: Results From the POST CABG Trial;http://www.ncbi.nlm.nih.gov/pubmed/15302735;General & Internal Medicine$ Respiratory System;2;Anxiety scale (Spielber);Aggressive LDL cholesterol;Moderate LDL cholesterol;Pharmacological;Scored;Acute;Assessed;Down;4;436;416;9.1;8.6;436;416;9.4;10.1;NA;NA;NA;0.2;Exact;No
2004;63;The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: a placebo-controlled, randomized clinical trial;http://www.ncbi.nlm.nih.gov/pubmed/15292331;Endocrinology & Metabolism;1;Body weight;Metformin ;Placebo;Pharmacological;Measured;Acute;Automatic;Down;2;29;26;20;13;29;26;21;12;NA;NA;NA;0.213;Exact;No
2004;64;Comparing the fixed combination dorzolamide-timolol (Cosopt) to concomitant administration of 2% dorzolamide (Trusopt) and 0.5% timolol -- a randomized controlled trial and a replacement study;http://www.ncbi.nlm.nih.gov/pubmed/15271105;Pharmacology & Pharmacy;1;Intraocular Pressure-IOP;Dorzolamide-timolol ;Topical carbonic anhydrase inhibitor;Pharmacological;Measured;Chronic;Automatic;Down;2;74;57;3.6;3.8;74;57;3.6;3.5;NA;NA;NA;0.34;Exact;No
2004;74;Vitamin E supplements in asthma: a parallel group randomised placebo controlled trial;http://www.ncbi.nlm.nih.gov/pubmed/15282383;Respiratory System;1;Serum vitamin E;Vitamin E;Placebo;Non-Pharmacological;Measured;Chronic;Automatic;Up;2;35;37;10.4;5.4;35;37;12.8;5.5;2.33;1.5;0.972;0.95;Exact;No
2004;76;Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial;http://www.ncbi.nlm.nih.gov/pubmed/15246726;General & Internal Medicine;1;Left ventricular ejection fraction;Bone-marrow-cell;Optimum postinfarction medical treatment;Non-Pharmacological;Measured;Acute;Automatic;Up;2;30;30;10;9.3;30;30;12.5;12.4;6.5;8.1;0.711;0.0026;Exact;Yes
2004;78;Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study;http://www.ncbi.nlm.nih.gov/pubmed/15225192;Obstetrics & Gynecology;1;Lipoprotein cholesterol;Conjugate equine estrogen + medroxyprogestrone acetate;Conugate equine estrogen + dydrogesterone;Pharmacological;Measured;None;Automatic;Down;2;140;139;0.44;0.38;133;130;0.39;0.43;NA;NA;NA;0.026;Exact;Yes
2004;80;Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status;http://www.ncbi.nlm.nih.gov/pubmed/15213041;Nutrition & Dietetics;1;Alpha-tocopherol;Vitamine E;Placebo;Non-Pharmacological;Measured;None;Automatic;Up;2;20;18;13.1;7.8;20;18;23.9;8.3;NA;NA;NA;NA;NA;No
2004;89;Effect of soluble fiber intake in lipid and glucose levels in healthy subjects: a randomized clinical trial;http://www.ncbi.nlm.nih.gov/pubmed/15163472;Endocrinology & Metabolism;1;HDL-cholesterol;Diet I (9.06 g fiber);Diet II (30.5 g fiber);Non-Pharmacological;Measured;None;Automatic;Down;2;26;27;0.4;0.5;26;27;0.3;0.4;NA;NA;NA;NA;NA;Yes
2004;93;Fluid resuscitation with colloids of different molecular weight in septic shock;http://www.ncbi.nlm.nih.gov/pubmed/15127186;General & Internal Medicine;1;Intrathoracic blood volume index;Fluid gelatine;Hydroxyethyl starch;Pharmacological;Measured;Acute;Automatic;Up;2;15;15;52;37;15;15;92;116;19;19;0.911;NA;NA;No
2004;97;Guided Tissue Regeneration With Bioabsorbable Barriers. II. Long-Term Results in Infrabony Defects;http://www.ncbi.nlm.nih.gov/pubmed/15341353;Dentistry, Oral Surgery & Medicine;1;Clinical attachment level;Polydioxanon;Polylactide acetyltributyl citrate;Pharmacological;Measured;Acute;Assessed;Up;2;13;13;1.32;1.6;13;13;2.17;1.87;1.8;1;0.507;0.811;Exact;No
2004;101;A randomized controlled clinical trial for low back pain treated by acupressure and physical therapy;http://www.ncbi.nlm.nih.gov/pubmed/15207999;Public, Environmental & Occupational Health$ General & Internal Medicine;2;Pain score;Acupressure;Physical therapy;Non-Pharmacological;Scored;Chronic;Assessed;Down;2;69;77;2.62;5.11;56;65;1.43;3.62;NA;NA;NA;0.0004;Exact;Yes
2004;108;Treatment of Acne Vulgaris With a Pulsed Dye Laser;http://www.ncbi.nlm.nih.gov/pubmed/15199033;General & Internal Medicine;1;Leeds score;Pulsed dye laser;No treatment;Non-Pharmacological;Measured;Acute;Assessed;Down;2;20;18;1.43;1.36;14;12;1.03;1.04;0.15;0.09;0.996;0.99;Exact;No
2004;110;Outcomes in a 2-phase randomized clinical trial of early Class II treatment;http://www.ncbi.nlm.nih.gov/pubmed/15179390;Dentistry, Oral Surgery & Medicine;1;Peer assessment rating;Functional appliance;Control;Non-Pharmacological;Scored;Acute;Assessed;Down;3;39;51;8.7;6.9;39;51;7.7;8.1;NA;NA;NA;0.35;Exact;No
2004;113;A randomized clinical trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosus;http://www.ncbi.nlm.nih.gov/pubmed/15188360;Rheumatology;1;Self efficacy;Psychoeducational intervention;Attention placebo;Non-Pharmacological;Scored;Chronic;Assessed;Up;2;64;58;2.3;2;41;49;1.9;2;NA;NA;NA;0.02;Exact;Yes
2004;114;Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial;http://www.ncbi.nlm.nih.gov/pubmed/15188371;Rheumatology;1;Psoriasis Area and Severity Index (PASI);Leflunomide;Placebo;Pharmacological;Scored;Chronic;Assessed;Down;2;92;90;5.5;8.8;92;90;6.5;8.7;5.9;6.1;0.664;0.003;Exact;Yes
2004;116;Catastrophizing and internal pain control as mediators of outcome in the multidisciplinary treatment of chronic low back pain;http://www.ncbi.nlm.nih.gov/pubmed/15109971;Anesthesiology$ Neurosciences & Neurology;2;Pain Rating Index;Operant-behavioral treatment;Waiting list control;Non-Pharmacological;Scored;Chronic;Assessed;Down;2;130;130;10;9.7;130;130;11.5;9.1;NA;NA;NA;NA;NA;No
2004;132;Effect of rosiglitazone on restenosis after coronary stenting in patients with type 2 diabetes;http://www.ncbi.nlm.nih.gov/pubmed/15131558;Cardiovascular System & Cardiology;1;Diameter stenosis;Roziglitazone;Placebo;Pharmacological;Measured;Chronic;Automatic;Down;2;8;8;8.2;10.2;8;8;26.1;28.3;NA;NA;NA;0.89;Exact;No
2004;134;Benefits of a School-Based Asthma Treatment Program in the Absence of Secondhand Smoke Exposure;http://www.ncbi.nlm.nih.gov/pubmed/15123479;Pediatrics;1;Number of parent-reported symptom-free day;Corticosteroids provided through  school;Corticosteroids non provided through  school;Pharmacological;Measured;Chronic;Assessed;Up;2;89;91;4.7;4.7;89;91;3.1;2.8;NA;NA;NA;0.38;Exact;No
2004;143;Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial;http://www.ncbi.nlm.nih.gov/pubmed/15111525;Endocrinology & Metabolism;1;HbA1c;Improved glycemic control;NPH insulin;Pharmacological;Measured;Chronic;Automatic;Down;3;137;132;1.2;1.19;132;124;0.8;0.78;NA;NA;NA;0.004;Exact;Yes
2004;148;Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea;http://www.ncbi.nlm.nih.gov/pubmed/15117375;Dermatology;1;Number of papules and pustules;Benzoyl peroxide/clindamycin gel;Vehicle-only gel;Pharmacological;Measured;Chronic;Assessed;Down;2;26;26;9.7;11.4;26;26;3.28;13.03;0.33;1.44;0.995;0.0003;Exact;Yes
2004;162;Long-term efficacy of therapy in patients with fibromyalgia: A physical exercise-based program and a cognitive-behavioral approach;http://www.ncbi.nlm.nih.gov/pubmed/15077258;Rheumatology;1;Aerobic exercise capacity;Physical exercise;Cognitive-behavioral therapy;Non-Pharmacological;Measured;Chronic;Automatic;Up;2;19;21;0.9;1.1;19;21;1.1;1.1;NA;NA;NA;NA;NA;No
2004;169;A 12-month, multicenter, randomized, double-masked, parallel-group comparison of timolol-LA once daily and timolol maleate ophthalmic solution twice daily in the treatment of adults with glaucoma or ocular hypertension;http://www.ncbi.nlm.nih.gov/pubmed/15189751;Pharmacology & Pharmacy;1;Intraocular Pressure-IOP;Timolol-LA;Timolol maleate ophthalmic;Pharmacological;Measured;Chronic;Automatic;Down;2;147;151;2.75;2.54;120;127;2.57;3.15;NA;NA;NA;NA;NA;No
2004;170;Low-Intensity Laser Therapy for Painful Symptoms of Diabetic Sensorimotor Polyneuropathy;http://www.ncbi.nlm.nih.gov/pubmed/15047649;Endocrinology & Metabolism;1;Pain score;Low-intensity laser therapy;Sham therapy;Non-Pharmacological;Scored;Acute;Assessed;Down;2;25;25;1.7;2.2;25;25;2.1;1.9;2;2;0.483;NA;NA;No
2004;187;Lipase inhibition by orlistat: effects on gall-bladder kinetics and cholecystokinin release in obesity;http://www.ncbi.nlm.nih.gov/pubmed/14987329;Gastroenterology & Hepatology$ Pharmacology & Pharmacy;2;Body weight;Orlistat;Placebo;Pharmacological;Measured;Acute;Automatic;Down;3;14;12;13.3;16.8;14;12;13.1;16.3;1.5;1.73;0.994;NA;NA;No
2004;201;Root Coverage Using the Coronally Positioned Flap With or Without a Subepithelial Connective Tissue Graft;http://www.ncbi.nlm.nih.gov/pubmed/15088880;Dentistry, Oral Surgery & Medicine;1;Recession depth;Subepithelial connective tissue graft plus coronally positioned flap;Coronally positioned flap;Non-Pharmacological;Scored;Acute;Assessed;Down;2;11;11;0.78;0.62;11;11;0.67;0.7;0.86;0.99;0.133;NA;NA;No
2004;220;Establishment of blood glucose monitoring system using the internet;http://www.ncbi.nlm.nih.gov/pubmed/14747232;Endocrinology & Metabolism;1;HbA1c;Internet-based blood glucose monitoring system;Usual care;Non-Pharmacological;Measured;Chronic;Automatic;Down;2;55;55;1.43;1.17;51;50;0.93;0.92;NA;NA;NA;0.001;Less than;Yes
2004;228;Isoflavones improve vascular reactivity in post-menopausal women with hypercholesterolemia;http://www.ncbi.nlm.nih.gov/pubmed/15230485;Cardiovascular System & Cardiology;1;Urinary Nitrates;Isoflavones daily;Placebo;Pharmacological;Measured;Acute;Automatic;Down;2;20;20;3.89;6.06;20;20;3.1;2.24;4.53;4.53;0.603;NA;NA;No
2004;233;A Randomized, Double-Blind, Multicenter, Controlled Clinical Trial of Cyclosporine Plus Chloroquine vs. Cyclosporine Plus Placebo in Early-Onset Rheumatoid Arthritis;http://www.ncbi.nlm.nih.gov/pubmed/15036798;Research & Experimental Medicine;1;Health Assessment Questionnaire Index;Cyclosporine-A + Chloroquine;Cyclosporine-A + Placebo;Pharmacological;Scored;Chronic;Assessed;Down;2;75;74;0.6;0.6;56;55;0.3;1.3;NA;NA;NA;0.44;Exact;No
2004;237;Measuring Health-Related Quality of Life in Adults During an Acute Asthma Exacerbation;http://www.ncbi.nlm.nih.gov/pubmed/14718426;General & Internal Medicine$ Respiratory System;2;Asthma Quality of Life Questionnaire (AQLQ);Formoterol;Salbutamol;Pharmacological;Scored;Chronic;Assessed;Up;2;44;44;0.96;1.14;44;44;0.85;1.07;NA;NA;NA;0.31;Exact;No
2004;251;Acupuncture and moxibustion in the treatment of active Crohn's disease: a randomized controlled study;http://www.ncbi.nlm.nih.gov/pubmed/15114043;Gastroenterology & Hepatology;1;Crohn's disease activity index;Traditional chinese medicine - acupuncture;Acupuncture;Non-Pharmacological;Scored;Chronic;Assessed;Down;2;26;20;51;47;26;20;49;53;43;46;0.596;NA;NA;No
2004;256;Raloxifene prevents the growth of uterine leiomyomas in premenopausal women;http://www.ncbi.nlm.nih.gov/pubmed/14711556;Obstetrics & Gynecology$ Reproductive Biology;2;Leiomyoma volume;Raloxifene;No treatment;Pharmacological;Measured;Acute;Automatic;Down;2;13;12;48.1;48;13;12;47.9;62.3;16.7;13.21;0.951;0.027;Exact;Yes
2004;259;Enamel matrix proteins in the treatment of intra-bony defects. A prospective 24-month clinical trial;http://www.ncbi.nlm.nih.gov/pubmed/15058375;Dentistry, Oral Surgery & Medicine;1;Probing pocket depth;Enamel matrix derivative (Emdogain) combined with surgical treatment;Surgical treatment;Pharmacological;Scored;Acute;Assessed;Down;2;12;12;1.46;1.25;12;12;0.82;1.6;1.95;1.15;0.306;0.00059;Exact;Yes
2007;4;Comparison of the effects of cetylpyridinium chloride with an essential oil mouth rinse on dental plaque and gingivitis – a six-month randomized controlled clinical trial;http://www.ncbi.nlm.nih.gov/pubmed/17635245;Dentistry, Oral Surgery & Medicine;1;Plaque Index;0.07% CPC Rinse (Crest Pro-Health);Essential oil (Listerine);Pharmacological;Measured;Acute;Assessed;Down;2;76;75;0.23;0.23;76;75;0.2;0.19;0.17;0.18;0.708;0.842;Exact;No
2007;9;Effect of soy protein-containing isoflavones on lipoproteins in postmenopausal women;http://www.ncbi.nlm.nih.gov/pubmed/17019375;Obstetrics & Gynecology;1;Total cholesterol;Soy;Placebo;Non-Pharmacological;Measured;None;Automatic;Down;2;107;109;26.43;24.77;107;109;26.57;27.65;NA;NA;NA;0.21;Exact;No
2007;19;A Randomized Clinical Trial of Two Methods of Fascia Lata Suspension in Congenital Ptosis;http://www.ncbi.nlm.nih.gov/pubmed/17519660;Ophthalmology$ Surgery;2;Eyelid fissure heigth;Group A: bitriangular fascia sling;Group B: monotriangular fascia sling;Non-Pharmacological;Measured;Chronic;Automatic;Down;2;15;15;1.6;2.3;15;15;1.3;1.4;2.3;2.2;0.355;0.4;Exact;No
2007;69;Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene;http://www.ncbi.nlm.nih.gov/pubmed/16842799;Cardiovascular System & Cardiology;1;Serum MCP-1;Conjugated Equine Estrogens;No treatment;Pharmacological;Measured;None;Automatic;Down;5;16;19;51;79.2;16;19;36.1;88.9;NA;NA;NA;NA;NA;Yes
2007;72;Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in Binge-Eating disorder;http://www.ncbi.nlm.nih.gov/pubmed/17915969;Psychology$ Psychiatry;2;Body weight;Topiramate;Placebo;Pharmacological;Measured;Acute;Automatic;Down;2;37;36;16.7;10.9;30;26;10.5;13.4;5.2;4.3;0.942;0.001;Less than;Yes
2007;78;The effect of Momordica charantia capsule preparation on glycemic control in Type 2 Diabetes Mellitus needs further studies;http://www.ncbi.nlm.nih.gov/pubmed/17493509;Health Care Sciences & Services$ Public, Environmental & Occupational Health;2;HbA1c;Momordica Charantia;Placebo;Pharmacological;Measured;Chronic;Automatic;Down;2;20;20;0.59;0.77;20;20;1.25;0.3;0.88;0.99;0.068;0.4825;Exact;No
2007;80;Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multi-center trial;http://www.ncbi.nlm.nih.gov/pubmed/17595258;Endocrinology & Metabolism;1;Height Standard Deviation Score-SDS;Growth Hormone (GH);Placebo;Pharmacological;Measured;Chronic;Automatic;Up;2;45;43;1;1.07;45;43;1.1;1.22;0.6;0.5;0.857;0.0001;Less than;Yes
2007;91;Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea;http://www.ncbi.nlm.nih.gov/pubmed/17556718;General & Internal Medicine$ Respiratory System;2;Carotid intima-media thicknees;Continuous positive airway pressure (CPAP);Placebo;Non-Pharmacological;Measured;Chronic;Automatic;Down;2;12;12;105;164;12;12;95;150;40.45;38.44;0.959;0.02;Exact;Yes
2007;97;Comparison of the ocular hypotensive efficacy of adjunctive Brimonidine 0.15% or Brinzolamide 1% in combination with Travoprost 0.004%;http://www.ncbi.nlm.nih.gov/pubmed/17509688;Ophthalmology;1;Intraocular Pressure-IOP (Diurnal);Brimonidine;Brianzolamine;Pharmacological;Measured;Chronic;Automatic;Down;2;79;84;0.33;0.29;79;84;0.41;0.33;0.27;0.25;0.649;0.019;Exact;Yes
2007;98;Effectiveness of a triclosan/copolymer dentifrice on dental plaque and gingivitis in Brazilian individuals with cerebral palsy;http://www.ncbi.nlm.nih.gov/pubmed/17972445;Neurosciences & Neurology$ Health Care Sciences & Services$ Dentistry, Oral Surgery & Medicine$ Pharmacology & Pharmacy$ Mathematics;5;Plaque Index;Dentifrice with triclosan;Conventional dentifrice with fluoride;Pharmacological;Measured;Acute;Assessed;Down;2;28;29;0.31;0.21;28;29;0.57;0.62;NA;NA;NA;0.4;Exact;No
2007;107;Is There a Subgroup of Patients With Low Back Pain Likely to Benefit From Mechanical Traction?: Results of a Randomized Clinical Trial and Subgrouping Analysis;http://www.ncbi.nlm.nih.gov/pubmed/18091473;Neurosciences & Neurology$ Orthopedics;2;Oswestry Low Back Pain Disability Questionnaire;Extension-oriented intervention with mechanical traction;Extension-oriented intervention without mechanical traction;Non-Pharmacological;Scored;Acute;Assessed;Down;2;31;33;14.9;10.7;31;33;19.3;19.9;NA;NA;NA;NA;NA;No
2007;113;Reduction in parafunctional activity: a potential mechanism for the effectiveness of splint therapy;http://www.ncbi.nlm.nih.gov/pubmed/17244231;Dentistry, Oral Surgery & Medicine;1;Facial pain change score;Avoid contact with the splint;Maintain light contact with the splint;Non-Pharmacological;Scored;Acute;Assessed;Down;2;5;9;1.92;1.23;5;9;0.85;1.11;NA;NA;NA;NA;NA;No
2007;130;Scleral Buckling versus primary vitrectomy in Rhegmatogenous Retinal Detachment: a prospective randomized multicenter clinical study;http://www.ncbi.nlm.nih.gov/pubmed/18054633;Ophthalmology;1;Visual acuity - BCVA;Scleral buckling surgery (SB);Primary pars plana vitrectomy (PPV);Non-Pharmacological;Measured;Acute;Automatic;Up;2;133;132;0.69;0.74;133;132;0.51;0.48;0.78;0.69;0.47;0.1033;Exact;No
2007;159;Emotional expression during attention-deficit/hyperactivity disorders treatment: initial assessment of treatment effects;http://www.ncbi.nlm.nih.gov/pubmed/17343553;Pediatrics$ Pharmacology & Pharmacy$ Psychiatry;3;Emotion scale for children -ESFC;Atomoxetine;Placebo;Pharmacological;Scored;Chronic;Assessed;Down;2;136;65;18.3;20.2;136;65;18.5;19.5;14.6;15.5;0.69;0.923;Exact;No
2007;161;Quetiapine for agitation or psychosis in patients with dementia and parkinsonism;http://www.ncbi.nlm.nih.gov/pubmed/17452579;Neurosciences & Neurology;1;Brief psychiatric rating scale-BPRS;Quetiapine;Placebo;Pharmacological;Scored;Chronic;Assessed;Down;2;19;17;8.8;8.7;19;17;8.9;7.6;7.8;6.9;0.644;0.38;Exact;No
2007;162;Intravitreal Triamcinolone plus Sequential Grid Laser versus Triamcinolone or Laser Alone for Treating Diabetic Macular Edema: six-month outcomes;http://www.ncbi.nlm.nih.gov/pubmed/17459479;Ophtalmology;1;Central foveal thickness-CFT ;Intravitreal+Laser;Laser;Pharmacological;Measured;Chronic;Automatic;Down;3;36;37;108;100;36;37;181;169;NA;NA;NA;0.49;Exact;No
2007;165;Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration;http://www.ncbi.nlm.nih.gov/pubmed/18046226;Ophtalmology;1;Visual acuity -  [ETDRS];Triamcinolone;Dexamethasone;Pharmacological;Measured;Chronic;Assessed;Up;2;21;18;0.4;0.38;21;18;0.34;0.52;0.38;0.48;0.398;0.06;Exact;No
2007;166;Effect of a milk drink supplemented with whey peptides on blood pressure in patients with mild hypertension;http://www.ncbi.nlm.nih.gov/pubmed/17180485;Nutrition & Dietetics;1;Systolic blood pressure;Milk drink;Placebo;Non-Pharmacological;Measured;Chronic;Automatic;Down;2;27;27;8.6;11.7;27;27;13.5;14.4;NA;NA;NA;NA;NA;No
2007;167;Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (The Rigenera study);http://www.ncbi.nlm.nih.gov/pubmed/17659916;Cardiovascular System & Cardiology;1;LV end-diastolic volume (LVEDV);G-CSF;Placebo;Pharmacological;Measured;Acute;Automatic;Down;2;13;27;33;35;13;27;46;41;36;41;0.34;0.1;Exact;No
2007;173;Improvement of insulin sensitivity and ?-cell function by nateglinide and repaglinide in type 2 diabetic patients - a randomized controlled double-blind and double-dummy multicentre clinical trial;http://www.ncbi.nlm.nih.gov/pubmed/17587398;Endocrinology & Metabolism;1;Fastingb blood glucose-BG;Repaglinide;Nateglinide;Pharmacological;Measured;Chronic;Automatic;Down;2;110;113;4.89;5.08;110;113;4.67;4.83;3.09;3.12;0.806;0.78;Exact;No
2007;178;Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases;http://www.ncbi.nlm.nih.gov/pubmed/17556414;Transplantation$ Urology & Nephrology;2;Glomerular Filtration Rate - GFR;Lead-Chelation;Placebo;Pharmacological;Measured;Chronic;Automatic;Up;2;58;58;12.7;11.2;58;58;13.1;11.4;8.8;8.4;0.742;0.7494;Exact;No
2007;187;Randomized controlled trial of interpersonal psychotherapy and cognitive-behavioural therapy for depression;http://www.ncbi.nlm.nih.gov/pubmed/17541109;Psychiatry;1;Montgomery Asber Depression Rating Scale (MADRS);IPT;CBT;Non-Pharmacological;Scored;Acute;Assessed;Down;2;91;86;6.5;6.2;91;86;9.6;9.4;7.67;8.05;0.236;0.059;Exact;No
2007;189;Effect of Pentoxifylline on inflammatory burden, oxidative stress and platelet aggregability in hypertensive type 2 diabetes mellitus patients;http://www.ncbi.nlm.nih.gov/pubmed/17613279;Pharmacology & Pharmacy;1;HbA1c;Pentoxifylline;Standard therapeutic regimen;Pharmacological;Measured;Acute;Automatic;Down;2;25;26;1.6;1.8;25;26;1.5;1.8;NA;NA;NA;0.001;Less than;Yes
2007;197;Effect of Surgically Removing Subcutaneous Fat by Abdominoplasty on Leptin Concentrations and Insulin Sensitivity;http://www.ncbi.nlm.nih.gov/pubmed/17413885;Surgery;1;Body mass index (BMI);Abdominoplasty;No intervention;Non-Pharmacological;Measured;Acute;Assessed;Down;2;6;6;0.9;1;6;6;0.7;0.9;NA;NA;NA;0.02;Exact;Yes
2007;201;Exercise Effect on Weight and Body Fat in Men and Women;http://www.ncbi.nlm.nih.gov/pubmed/17557987;Endocrinology & Metabolism$ Nutrition & Dietetics;2;Body weight;Aerobic activity;No intervention;Non-Pharmacological;Measured;None;Automatic;Down;2;49;51;17.8;12.8;49;51;17.4;13.5;NA;NA;NA;0.008;Exact;Yes
2007;202;The COPE Healthy Lifestyles TEEN Program: Feasibility, Preliminary Efficacy, & Lessons Learned from an After School Group Intervention with Overweight Adolescents;http://www.ncbi.nlm.nih.gov/pubmed/17825729;Pediatrics$ Psychology$ General & Internal Medicine$ Nursing$ Nutrition & Dietetics$ Health Care Sciences & Services;6;Body weight;COPE Healthy Lifestyles TEEN Program;Control;Non-Pharmacological;Measured;Acute;Automatic;Down;2;7;5;83.71;25.99;7;5;43.14;20.9;NA;NA;NA;0.03;Exact;Yes
2007;208;A Randomized Controlled Clinical Trial of Psychoanalytic Psychotherapy for Panic Disorder;http://www.ncbi.nlm.nih.gov/pubmed/17267789;Psychiatry;1;Panic disorder severity scale;Panic-focused psychodinamic psychotherapy;Applied relaxation training;Non-Pharmacological;Scored;Acute;Assessed;Down;2;26;23;4;4;26;23;4;4.6;NA;NA;NA;0.002;Exact;Yes
2007;231;Visfatin: A Putative Biomarker for Metabolic Syndrome is not Influenced by Pioglitazone or Simvastatin Treatment in Nondiabetic Patients at Cardiovascular Risk - Results from the PIOSTAT Study;http://www.ncbi.nlm.nih.gov/pubmed/17952841;Endocrinology & Metabolism;1;HOMAir-score;Simvastatin + Placebo;Pioglitazone + Placebo;Pharmacological;Measured;None;Automatic;Down;3;43;41;12.7;8.2;43;41;7;14.5;NA;NA;NA;NA;NA;Yes
2007;232;Relief of Idiopathic Subjective Tinnitus: is gabapentin effective?;http://www.ncbi.nlm.nih.gov/pubmed/17438255;Otorhinolaryngology$ Surgery;2;Tinnitus handicap inventory score;Gabapentin;Placebo;Pharmacological;Scored;Acute;Assessed;Down;2;59;56;17.85;18.03;59;56;23.52;19.02;NA;NA;NA;0.63;Exact;No
2007;252;Sit-to-stand as home exercise for mobility-limited adults over 80 years of age - grandstand system may keep you standing?;http://www.ncbi.nlm.nih.gov/pubmed/17646216;Geriatrics & Gerontology;1;Comfortable gait speed;Grand stand system;Knee extension;Pharmacological;Measured;None;Automatic;Up;2;33;33;0.18;0.2;33;33;0.18;0.23;0.16;0.12;0.724;0.702;Exact;No
2007;253;Comparison of the effects of Bimatoprost and a fixed combination of Latanoprost and timolol on circadian intraocular pressure;http://www.ncbi.nlm.nih.gov/pubmed/17459480;Ophthalmology;1;Intraocular Pressure-IOP;Bimatoprost;Latanoprost and Timolol Fixed Combination (LTFC);Pharmacological;Measured;Chronic;Automatic;Down;2;101;99;3.3;2.9;101;99;2.5;3.7;3.5;2.5;0.52;NA;NA;No
2007;277;Intravitreal Bevacizumab (Avastin) injection alone ore combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema;http://www.ncbi.nlm.nih.gov/pubmed/18046223;Ophthalmology;1;Visual acuity - VA [logMAR];IVB;MPC;Pharmacological;Measured;Chronic;Automatic;Up;3;37;33;0.28;0.25;37;33;0.33;0.39;0.23;0.31;0.483701062;0.003;Exact;Yes
2007;283;Objectively monitored patching regimens for treatment of amblyopia: randomised trial;http://www.ncbi.nlm.nih.gov/pubmed/17855283;General & Internal Medicine;1;Visual acuity [log MAR];Occlusion 6 hours/day;Occlusion12 hours/day;Non-Pharmacological;Measured;Chronic;Automatic;Up;2;40;40;0.3;0.3;40;40;0.19;0.19;0.12;0.14;0.907;0.64;Exact;No
2007;298;Effectiveness of Transcutaneous Electrical Nerve Stimulation and Interferential Current in Primary Dysmenorrhea;http://www.ncbi.nlm.nih.gov/pubmed/17610451;General & Internal Medicine;1;Intensity menstrual pain [VAS];Interferential current;Transcutaneous electrical nerve stimulation;Non-Pharmacological;Scored;Acute;Assessed;Down;2;15;17;16.5;15.6;15;17;19.3;21.2;NA;NA;NA;0.923;Exact;No
2007;302;Randomized controlled trial of the effects of print materials and step pedometers on physical activity and quality of life in breast cancer survivors;http://www.ncbi.nlm.nih.gov/pubmed/17557948;Oncology;1;Self-reported physical activity (PA);Print Material;Standard recommendation;Non-Pharmacological;Measured;Chronic;Assessed;Up;4;94;96;159;144;94;96;160;121;151.07;148.42;0.512;0.117;Exact;No
2007;320;Change factors explaining reductions of interference in a multidisciplinary and an exercise prevention program for low back pain;http://www.ncbi.nlm.nih.gov/pubmed/17710014;Anesthesiology$ Neurosciences & Neurology;3;Interference with daily life owing to pain;Multidisciplinary program;Exercise program;Non-Pharmacological;Scored;Acute;Assessed;Down;2;80;82;1.12;1.14;80;82;0.9;1.14;NA;NA;NA;0.001;Less than;Yes
2007;323;L-Arginine Supplementation in Peripheral Arterial Disease;http://www.ncbi.nlm.nih.gov/pubmed/17592080;Cardiovascular System & Cardiology;1;Absolute claudication distance;L-Arginine;Placebo;Pharmacological;Measured;Chronic;Automatic;Up;2;58;61;16;19;58;61;25;28;17;16;0.561;0.09;Exact;No
2007;326;One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk;http://www.ncbi.nlm.nih.gov/pubmed/17923653;General & Internal Medicine;1;Framingham global risk score;Health report card with counselling;Usual care;Non-Pharmacological;Measured;None;Assessed;Down;2;157;158;5.9;6;157;158;5.33;5.47;5.52;5.54;0.569;0.002;Exact;Yes
2007;332;Acid-based analysis of individuals following two weight loss diet;http://www.ncbi.nlm.nih.gov/pubmed/17299473;Nutrition & Dietetics;1;Serum pH;Low-Carbohydrate, ketogenic diet (LCKD);Low-fat diet (LFD);Non-Pharmacological;Measured;None;Automatic;Down;2;27;12;0.02;0.02;27;12;0.03;0.03;0.04;0.03;-0.489;0.6;Exact;No
2007;343;Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial;http://www.ncbi.nlm.nih.gov/pubmed/17419678;Endocrinology & Metabolism;1;Bone mineral density at femoral neck;Epimedium-derived phytoestrogen flavonoids;Placebo;Non-Pharmacological;Measured;None;Automatic;Up;2;50;50;0.04;0.04;50;50;0.05;0.04;NA;NA;NA;0.061;Exact;No
2010;1;Effect of cilnidipine vs losartan on cerebral blood flow in hypertensive patients with a history of ischemic stroke: a randomized controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/19925528;Neurosciences & Neurology;1;Global Cerebral Blood Flow;cilnidipine 10-20 mg;losartan 50-100 mg;Pharmacological;Measured;Chronic;Automatic;Up;2;83;84;11;12.1;83;84;11.4;12.2;NA;NA;NA;NA;NA;No
2010;13;Effects of an exercise and manual therapy program on physical impairments, function and quality-of-life in people with osteoporotic vertebral fracture: a randomised, single-blind controlled pilot trial.;http://www.ncbi.nlm.nih.gov/pubmed/20163739;Orthopedics$ Rheumatology;2;Average back pain;individual sessions with an experienced clinician once a week for 10 weeks and performed daily home exercises with adherence monitored by a self-report diary;no treatment;Non-Pharmacological;Scored;Acute;Assessed;Down;2;11;9;2.7;2;11;9;2.3;1.8;2.4;1.4;0.651;NA;NA;Yes
2010;21;Treatment of childhood obesity by retraining eating behaviour: randomised controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/20051465;General & Internal Medicine;1;BMI SDS;A computerised device, Mandometer, providing real time feedback to participants during meals to slow down speed of eating and reduce total intake: standard lifestyle modification therapy.;standard care;Non-Pharmacological;Measured;Acute;Automatic;Down;2;45;46;0.55;0.45;45;46;0.72;0.57;0.34;0.35;0.765;0.001;Less than;Yes
2010;24;Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/21106625;General & Internal Medicine;1;Diurnal systolic blood pressure;CPAP;sham CPAP;Non-Pharmacological;Measured;Acute;Automatic;Down;2;137;135;12;11;137;135;13;13;NA;NA;NA;0.07;Exact;No
2010;42;Long-term daily high and low doses of azithromycin in children with cystic fibrosis: a randomized controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/19818694;Respiratory System;1;FEV1;5 mg/kg/day azithormycin;15 mg/kg/day azithromycin;Pharmacological;Measured;Chronic;Automatic;Up;2;24;23;23.5;14.8;8;9;19.39;14.57;NA;NA;NA;0.4354;Exact;No
2010;46;Supplementation with a whey protein hydrolysate enhances recovery of muscle force-generating capacity following eccentric exercise.;http://www.ncbi.nlm.nih.gov/pubmed/18768358;Sport Sciences;1;Plasma TNF;Hydrolysate of whe protein isolate;Flavoured water Placebo;Non-Pharmacological;Measured;Acute;Automatic;Down;3;6;11;0.32;0.53;6;11;0.27;0.46;NA;NA;NA;0.58;Exact;No
2010;48;Enhancing Caregiver Health: Findings from the Resources for Enhancing Alzheimer's Caregiver Health II Intervention;http://www.ncbi.nlm.nih.gov/pubmed/20122038;Geriatrics & Gerontology;1;Caregiver health status (self-rated health);REACH intervention;Placebo;Non-Pharmacological;Scored;Chronic;Assessed;Down;2;257;238;0.82;0.81;257;238;0.95;0.77;NA;NA;NA;0.01;Less than;Yes
2010;51;The effects of a commercially available botanical supplement on strength, body composition, power output, and hormonal profiles in resistance-trained males.;http://www.ncbi.nlm.nih.gov/pubmed/20979623;Nutrition & Dietetics$ Sport Sciences;2;Bench press 1RM;500g of Fenugreek;Placebo;Non-Pharmacological;Measured;None;Automatic;Up;2;26;23;26;22;26;23;27;22;NA;NA;NA;NA;NA;Yes
2010;57;Efficacy of different strategies to treat anemia in children: a randomized clinical trial.;http://www.ncbi.nlm.nih.gov/pubmed/20863398;Nutrition & Dietetics;1;Hemoglobin;iron+folic acid supplement;iron supplement;Non-Pharmacological;Measured;Acute;Automatic;Up;5;42;40;0.76;0.87;42;40;1.12;1.06;1.29;1.13;-0.1092636;0.001;Exact;Yes
2010;60;SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy.;http://www.ncbi.nlm.nih.gov/pubmed/20808854;Science & Technology - Other Topics;1;Hammersmith Functional Motor Scale (MHFMS) score;L-carnitine and VPA;Placebo;Pharmacological;Scored;Chronic;Assessed;Up;2;30;31;8.7;9.3;30;31;7.9;8.1;2.88;3.98;0.925;0.079;Exact;No
2010;79;Effects of a wobble board-based therapeutic exergaming system for balance training on dynamic postural stability and intrinsic motivation levels.;http://www.ncbi.nlm.nih.gov/pubmed/20044704;Orthopedics$ Rehabilitation$ Sport Sciences;3;Anterior SEBT (star excursion balance test) ;exergaming approaches to wobble board training;conventional approaches to wobble board training;Non-Pharmacological;Scored;None;Automatic;Up;2;11;11;4.7;5.3;11;11;4;6.5;NA;NA;NA;0.84;Exact;No
2010;89;Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial.;http://www.ncbi.nlm.nih.gov/pubmed/19815809;General & Internal Medicine$ Respiratory System;2;Asthma Quality of Life Questionnaire (AQLQ);Bronchial thermoplasty (BT);sham Control;Non-Pharmacological;Scored;Chronic;Assessed;Up;2;190;98;1.17;1.21;190;98;1.06;1.15;1.1;1.23;0.532;0.04;Exact;Yes
2010;91;Exercise effects on bone mineral density, falls, coronary risk factors, and health care costs in older women: the randomized controlled senior fitness and prevention (SEFIP) study.;http://www.ncbi.nlm.nih.gov/pubmed/20101013;General & Internal Medicine;1;Bone mineral density at lumbar spine, g/cm2;exercise program;wellness program;Non-Pharmacological;Measured;None;Automatic;Up;2;115;112;0.16;0.15;115;112;0.17;0.15;0.03;0.03;0.984;0.01;Less than;Yes
2010;94;Escitalopram and enhancement of cognitive recovery following stroke;http://www.ncbi.nlm.nih.gov/pubmed/20124118;Psychiatry;1;RBANS score;Escitalopram;Placebo;Pharmacological;Scored;Acute;Automatic;Up;3;43;45;16.8;14.4;43;45;15.1;17.8;NA;NA;NA;0.01;Less than;Yes
2010;97;A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease.;http://www.ncbi.nlm.nih.gov/pubmed/20056760;Urology & Nephrology;1;PTH;cholecalciferol;doxercalciferol;Pharmacological;Measured;Chronic;Automatic;Down;2;22;25;43;44;20;20;49;49;NA;NA;NA;0.19;Exact;No
2010;104;Comparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes-results of the GINGER study.;http://www.ncbi.nlm.nih.gov/pubmed/20092584;Endocrinology & Metabolism;1;HbA1c;once-daily insulin glargine and mealtime glulisine;twice-daily premized insulin;Pharmacological;Measured;Chronic;Automatic;Down;2;153;157;0.83;0.86;153;157;1.16;1.14;1.19;1.01;0.149;0.3315;Exact;No
2010;108;Manipulative therapy in addition to usual care for patients with shoulder complaints: results of physical examination outcomes in a randomized controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/20170774;Health Care Sciences & Services$ Integrative & Complementary Medicine$ Rehabilitation;3;Shoulder pain;UC;UC+AMT;Non-Pharmacological;Scored;Acute;Assessed;Down;2;71;79;5.6;4.5;71;79;4;4;NA;NA;NA;NA;NA;Yes
2010;111;Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/19815048;Neurosciences & Neurology$ Pharmacology & Pharmacy$ Psychiatry;3;Parent ADHD Rating Scale (inattentive);Ginkgo biloba;ritalin;Non-Pharmacological;Scored;Chronic;Assessed;Down;2;25;25;4.25;5.43;25;25;8.45;6.45;NA;NA;NA;0.02;Exact;Yes
2010;114;A randomized comparative trial of generalized vs targeted physiotherapy in the management of childhood hypermobility.;http://www.ncbi.nlm.nih.gov/pubmed/19948753;Rheumatology;1;Child's pain assesment score;targeted physiotherapy;generalize physiotherapy;Non-Pharmacological;Scored;Chronic;Assessed;Down;2;30;27;21.32;24.14;17;15;23.37;26.01;33.07;37.34;-0.198;0.71;Exact;No
2010;129;Randomized, double-blind, controlled study of losartan in children with proteinuria.;http://www.ncbi.nlm.nih.gov/pubmed/20089489;Urology & Nephrology;1;Upr/Cr on the natural logarithm scale;losartan;amlodipine/Placebo;Pharmacological;Measured;Acute;Automatic;Down;4;152;154;2.3;4.81;145;143;2.48;6.73;NA;NA;NA;0.001;Less than;Yes
2010;132;Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy;http://www.ncbi.nlm.nih.gov/pubmed/19874395;Neurosciences & Neurology;1;Alzheimer's Disease Assessment Scale (ADAS-cog);donepezil;memantine;Pharmacological;Scored;Chronic;Automatic;Down;2;32;31;8.42;8.9;32;31;9.6;9.2;NA;NA;NA;0.6;Exact;No
2010;133;Lupin protein compared to casein lowers the LDL cholesterol:HDL cholesterol-ratio of hypercholesterolemic adults;http://www.ncbi.nlm.nih.gov/pubmed/19680704;Nutrition & Dietetics;1;LDL cholesterol concentration;casein;lupin protein;Non-Pharmacological;Measured;Chronic;Automatic;Down;2;21;22;0.64;0.65;21;22;0.73;0.64;0.62;0.46;0.645;0.38;Exact;No
2010;137;Treatment of functional constipation with the Yun-chang capsule: A double-blind, randomized, placebo-controlled, dose-escalation trial;http://www.ncbi.nlm.nih.gov/pubmed/20370727;Gastroenterology & Hepatology;1;Main symptom score;35 mg x 3 capsules of YCC;35 mg x 2 capsules of YCC plus 35 mg x 1 capsule of placebo;Non-Pharmacological;Scored;Acute;Assessed;Down;2;43;44;3.92;2.8;43;44;2.78;2.18;4.1;3.35;0.395;0.0001;Less than;Yes
2010;143;Ultrasonographic evaluation of plantar fasciitis after low-level laser therapy: results of a double-blind, randomized, placebo-controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/19841862;Engineering$ Surgery;2;Plantar fascia thickness;laser group;Placebo;Non-Pharmacological;Measured;Acute;Automatic;Down;2;15;10;1.32;1.19;15;10;0.92;1;0.55;0.22;0.938;0.007;Exact;Yes
2010;145;Hormone therapy and physical function change among older women in the Women's Health Initiative: a randomized controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/19858764;Obstetrics & Gynecology;1;Grip Strength;estrogen therapy;Placebo;Pharmacological;Scored;None;Automatic;Up;2;385;396;0.17;0.16;342;354;0.38;0.36;NA;NA;NA;0.285;Exact;No
2010;148;Pediatric endurance and limb strengthening (PEDALS) for children with cerebral palsy using stationary cycling: a randomized controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/20093327;Orthopedics$ Rehabilitation;2;600-Yard Walk-Run Test speed (m/min);cycling group;Control group;Non-Pharmacological;Measured;Chronic;Automatic;Up;2;27;28;40.83;42.66;27;28;40.03;44.82;10.34;9.45;0.972;0.24;Exact;No
2010;151;Adding motivational interviewing and thought mapping to cognitive-behavioral group therapy: results from a randomized clinical trial.;http://www.ncbi.nlm.nih.gov/pubmed/20339731;Psychiatry;1;Dimensional Yale-Brown Obsessive-Compulsive Scale;motivational interviewing+thought mapping plus cognitive-behavioral group therapy;cognitive-behavioral group therapy (Control group);Non-Pharmacological;Scored;Chronic;Assessed;Down;2;20;20;2.6;3.5;20;20;4.4;8.3;NA;NA;NA;0.062;Exact;No
2010;153;A randomized controlled single-blinded comparison of stretching versus stretching and joint mobilization for posterior shoulder tightness measured by internal rotation motion loss.;http://www.ncbi.nlm.nih.gov/pubmed/23015927;NA;0;Passive shoulder internal rotation;stretching;stretching plus posterior joint mobilizations;Non-Pharmacological;Measured;Acute;Automatic;Up;2;20;19;9.3;10;20;19;11.1;11.6;NA;NA;NA;NA;NA;No
2010;163;Results of intracoronary stem cell therapy after acute myocardial infarction.;http://www.ncbi.nlm.nih.gov/pubmed/20211323;Cardiovascular System & Cardiology;1;Left ventricular ejection fraction;Intracoronary bone-marrow cell;Placebo;Non-Pharmacological;Measured;Acute;Automatic;Up;2;28;12;9.3;9.4;28;12;9.6;11.2;5.3;8.4;0.768;0.1;Exact;No
2010;164;Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial.;http://www.ncbi.nlm.nih.gov/pubmed/20194881;Cardiovascular System & Cardiology;1;Atheroma volume in the longest and least angulated epicardial coronary atery;glipizide;rosiglitazone;Pharmacological;Measured;Chronic;Automatic;Down;2;229;233;11;11.8;229;233;11.2;11.4;5.02;5.06;0.902;0.12;Exact;No
2010;168;Additive beneficial effects of lactotripeptides intake with regular exercise on endothelium-dependent dilatation in postmenopausal women.;http://www.ncbi.nlm.nih.gov/pubmed/20075849;Cardiovascular System & Cardiology;1;Brachial artery diameter (mm);Lactotripeptides;Placebo;Non-Pharmacological;Measured;Acute;Automatic;Down;4;12;10;0.69;0.32;12;10;0.69;0.32;NA;NA;NA;NA;NA;No
2010;191;Comparison of Ponseti and Kite's method of treatment for idiopathic clubfoot.;http://www.ncbi.nlm.nih.gov/pubmed/20419009;Orthopedics;1;Pirani club foot score (hindfoot);Ponseti method;Kite method;Non-Pharmacological;Scored;Chronic;Assessed;Down;2;12;12;0.46;0.33;12;12;0.27;0.4;NA;NA;NA;0.0001;Less than;Yes
2010;204;Low-dose amitriptyline for treatment of persistent arm pain due to repetitive use.;http://www.ncbi.nlm.nih.gov/pubmed/20172654;Anesthesiology$ Neurosciences & Neurology;2;Intensity of pain;Amitriptyline;Placebo;Pharmacological;Scored;Acute;Assessed;Down;2;59;59;1.8;1.8;59;59;1.8;1.9;1.5;1.8;0.576;0.277;Exact;No
2010;225;An internet-based physical activity intervention for adolescents with cerebral palsy: a randomized controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/20132138;Neurosciences & Neurology$ Pediatrics;2;Weekly step counts;8-week internet-based, lifestyle physical-activity;Control;Non-Pharmacological;Measured;Chronic;Automatic;Up;2;20;21;28.1;22.2;19;21;30.09;28.34;NA;NA;NA;0.14;Exact;No
2010;235;The Medicine Wheel nutrition intervention: a diabetes education study with the Cheyenne River Sioux Tribe.;http://www.ncbi.nlm.nih.gov/pubmed/20399298;Nutrition & Dietetics;1;HbA1c;six nutrition lessons;usual dietary education;Non-Pharmacological;Measured;Chronic;Automatic;Down;2;51;53;2.86;2.18;51;53;2.14;2.18;2.14;1.46;0.741;0.5563;Exact;No
2010;238;Hip strengthening reduces symptoms but not knee load in people with medial knee osteoarthritis and varus malalignment: a randomised controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/20175973;Orthopedics$ Rheumatology;2;Peak external knee adduction moment;hip strengthening group;no intervention;Non-Pharmacological;Measured;Chronic;Automatic;Down;2;39;37;1;0.9;39;37;0.9;0.9;0.07;0.07;0.997;0.193;Exact;No
2010;253;Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/20442386;General & Internal Medicine;1;FEV1;azithromycin;Placebo;Pharmacological;Measured;Chronic;Automatic;Up;2;131;129;0.85;0.85;131;126;0.86;0.88;NA;NA;NA;0.61;Exact;No
2010;256;Low vs. Higher-dose dark chocolate and blood pressure in cardiovascular high-risk patients.;http://www.ncbi.nlm.nih.gov/pubmed/20203627;Cardiovascular System & Cardiology;1;Blood pressure (24h);6 g/day of flavanol-rich dark chocolate;25 g/day of flavanol-rich dark chocolate;Non-Pharmacological;Measured;Chronic;Automatic;Down;2;48;43;6.6;6.8;48;43;8.5;7.5;6.72;5.69;0.564;0.77;Exact;No
2010;259;Effect of fluid management on fluid intake and urge incontinence in a trial for overactive bladder in women.;http://www.ncbi.nlm.nih.gov/pubmed/19912207;Urology & Nephrology;1;Leakage episodes/24 h;tolterodine;tolterodine combined with behavioural therapies;Pharmacological;Measured;Acute;Automatic;Down;2;153;154;2.6;2.6;153;154;2.8;2.8;NA;NA;NA;0.41;Exact;No
2010;280;Neurotherapy of fibromyalgia?;http://www.ncbi.nlm.nih.gov/pubmed/20624243;General & Internal Medicine;1;Fibromyalgia Impact Questionnaire;Active LENS;Sham;Non-Pharmacological;Scored;Chronic;Assessed;Down;2;16;16;11.46;6.46;16;16;14.41;11.53;NA;NA;NA;NA;NA;No
2010;284;Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial;http://www.ncbi.nlm.nih.gov/pubmed/20410089;Nutrition & Dietetics;1;CVLT (total words correct in first 3 trials);fish oil;Placebo;Non-Pharmacological;Measured;None;Automatic;Up;2;375;369;6;5.7;375;369;6.7;6.4;4.7;5;0.657;0.14;Exact;No
2010;285;The effects of probiotic and conventional yoghurt on lipid profile in women.;http://www.ncbi.nlm.nih.gov/pubmed/20100374;Nutrition & Dietetics;1;Total cholesterol (mmol/l);Conventional yoghurt;Probiotic yoghurt;Non-Pharmacological;Measured;None;Automatic;Down;3;30;29;0.66;0.62;30;29;0.58;0.66;NA;NA;NA;NA;NA;No
2010;286;Complex mental and physical activity in older women and cognitive performance: a 6-month randomized controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/20418350;Geriatrics & Gerontology;1;RBMT immediate recall;Exercise;Control condition;Non-Pharmacological;Scored;None;Automatic;Up;3;91;76;2.3;2.5;80;81;2.6;2.28;2.57;3.02;0.312778503;0.007;Exact;Yes
2010;287;Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/20452823;Neurosciences & Neurology;1;Beck depression inventory (BDI) score;Pramipexole;Placebo;Pharmacological;Scored;Chronic;Assessed;Down;2;144;152;8;8.6;139;148;5.89;6.08;5.89;6.08;0.74;0.035;Exact;Yes
2010;291;Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial.;http://www.ncbi.nlm.nih.gov/pubmed/20609969;General & Internal Medicine;1;HbA1c;exenatide once weekly;insulin glargine;Pharmacological;Measured;Chronic;Automatic;Down;2;233;223;1.1;1;228;220;0.75;0.89;0.75;0.89;0.693;0.0003;Exact;Yes
2010;317;Effect of glucosamine on pain-related disability in patients with chronic low back pain and degenerative lumbar osteoarthritis: a randomized controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/20606148;General & Internal Medicine;1;Roland-Morris Disability Questionnaire (RMDQ) ;daily 1500 g glucosamine;Placebo;Pharmacological;Scored;Chronic;Assessed;Down;2;125;125;3.9;4.5;125;125;4.56;4.56;NA;NA;NA;0.5;Exact;No
2010;319;Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/20619448;General & Internal Medicine;1;Systolic blood pressure;selfmanagement, consisting of self-monitoring of blood pressure and self-titration of antihypertensive drugs, combined with telemonitoring of home blood pressure measurements;usual care;Non-Pharmacological;Measured;Chronic;Automatic;Down;2;234;246;11.71;12;234;246;15.61;17.6;17.17;17.6;-0.076;NA;NA;Yes
2010;332;Impact of acarbose on carotid intima-media thickness in patients with newly diagnosed impaired glucose tolerance or mild type 2 diabetes mellitus: A one-year, prospective, randomized, open-label, parallel-group study in Japanese adults with established coronary artery disease.;http://www.ncbi.nlm.nih.gov/pubmed/20974318;Pharmacology & Pharmacy;1;Largest measured IMT value in the right and left common carotid arteries;acarbose 150 mg/d;no treatment;Pharmacological;Measured;Chronic;Automatic;Down;2;42;39;0.53;0.37;42;39;0.52;0.46;0.29;0.25;0.826;0.002;Exact;Yes
2010;353;The incorporation of marine n-3 PUFA into platelets and adipose tissue in pre- and postmenopausal women: a randomised, double-blind, placebo-controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/20334707;Nutrition & Dietetics;1;Palmitic acid (16:0);2·2 g of marine n-3 PUFA (premenopausal);Control oil (premenopausal);Non-Pharmacological;Measured;Acute;Automatic;Up;2;23;22;1;0.9;23;22;1.1;1.1;NA;NA;NA;NA;NA;Yes
2010;354;A randomized controlled trial of the effect of thyroxine replacement on cognitive function in community-living elderly subjects with subclinical hypothyroidism: the Birmingham Elderly Thyroid study.;http://www.ncbi.nlm.nih.gov/pubmed/20501682;Endocrinology & Metabolism;1;Hospital Anxiety and Depression Scale (HADS);T4;Placebo;Pharmacological;Scored;Chronic;Assessed;Down;2;52;42;2.67;2.92;49;36;2.52;2.82;NA;NA;NA;0.82;Exact;No
2010;357;Effect of an advocacy intervention on mental health in Chinese women survivors of intimate partner violence: a randomized controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/20682933;General & Internal Medicine;1;Chinese version of the Beck Depression Inventory II;12-week advocacy intervention comprising empowerment and telephone social support;usual community services including child care, health care and promotion, and recreational programs;Non-Pharmacological;Scored;None;Assessed;Down;2;100;100;14.9;15.6;100;100;10.69;11.4;14.29;15.82;0.512;0.03;Exact;Yes
2010;358;Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial.;http://www.ncbi.nlm.nih.gov/pubmed/20580422;General & Internal Medicine;1;HbA1c;exenatide once weekly;sitagliptin once daily;Pharmacological;Measured;Chronic;Automatic;Down;3;160;166;1.2;1.2;160;166;1.26;1.29;0.65;1.31;0.623;0.0001;Less than;Yes
2010;389;Methotrexate versus traditional Chinese medicine in psoriasis: a randomized, placebo-controlled trial to determine efficacy, safety and quality of life;http://www.ncbi.nlm.nih.gov/pubmed/19925489;Dermatology;1;Psoriasis Area and Severity Index (PASI);Methotrexate;Placebo;Pharmacological;Scored;Chronic;Assessed;Down;3;19;17;11.3;10.8;19;17;8.5;10.1;NA;NA;NA;0.01;Less than;Yes
2010;391;Quality-of-life measures in children and adults with type 1 diabetes: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial.;http://www.ncbi.nlm.nih.gov/pubmed/20696865;Endocrinology & Metabolism;1;Hypoglycemia Fear Survey (HFS) total score;CGM;Control;Non-Pharmacological;Scored;Chronic;Assessed;Down;2;122;106;12.8;14.3;120;106;11.5;13.6;NA;NA;NA;0.04;Exact;Yes
2010;393;Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitus.;http://www.ncbi.nlm.nih.gov/pubmed/20824678;Endocrinology & Metabolism;1;HbA1c;saxagliptin+metformin;sitagliptin+metformin;Pharmacological;Measured;Chronic;Automatic;Down;2;334;343;0.95;0.87;334;343;0.95;0.94;0.71;0.7;0.698;NA;NA;No
2010;401;Eicosapentaenoic acid as an add-on to antidepressant medication for co-morbid major depression in patients with diabetes mellitus: a randomized, double-blind placebo-controlled study;http://www.ncbi.nlm.nih.gov/pubmed/20466431;Neurosciences & Neurology$ Psychiatry;2;Montgomery Asber Depression Rating Scale (MADRS);E-EPA (1 g/day);Placebo;Pharmacological;Scored;Acute;Assessed;Down;2;13;12;8.2;8.7;12;12;6.9;9.1;NA;NA;NA;0.17;Exact;No
2010;414;Diabetes control with reciprocal peer support versus nurse care management: a randomized trial.;http://www.ncbi.nlm.nih.gov/pubmed/20956707;General & Internal Medicine;1;HbA1c;Reciprocal Peer Support;Nurse Care Management;Non-Pharmacological;Measured;Chronic;Automatic;Down;2;125;119;1.32;1.4;113;103;1.32;1.74;NA;NA;NA;0.004;Exact;Yes
2010;416;G-CSF in patients suffering from late revascularised ST elevation myocardial infarction: final 1-year-results of the G-CSF-STEMI Trial.;http://www.ncbi.nlm.nih.gov/pubmed/19477537;Cardiovascular System & Cardiology;1;Ejection fraction (%);G-CSF (Filgrastim) at a dose of 10 ?g/kg body weight/day subcutaneously;Placebo;Pharmacological;Measured;Acute;Automatic;Up;2;23;21;11.9;9;23;21;15.1;15.4;12.6;11.8;0.337;0.666;Exact;No
2010;421;Effect of creatine supplementation as a potential adjuvant therapy to exercise training in cardiac patients: a randomized controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/20576665;Rehabilitation;1;HR at rest (bpm);Creatine;Placebo;Non-Pharmacological;Measured;Chronic;Automatic;Down;2;33;37;10.9;8.7;33;37;10.6;9.2;NA;NA;NA;0.24;Exact;No
2010;427;Transcranial magnetic stimulation and volitional quadriceps activation;http://www.ncbi.nlm.nih.gov/pubmed/21062180;Sport Sciences;1;Central Activation Ratio;Transcranial Magnetic Stimulation;3 maximal quadriceps contractions without TMS;Non-Pharmacological;Measured;Acute;Automatic;Up;2;11;9;11.6;10.5;11;9;11.3;11;NA;NA;NA;0.76;Exact;No
2010;439;Effects of soy consumption on serum lipids and apoproteins in peritoneal dialysis patients: a randomized controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/20378840;Urology & Nephrology;1;Lp(a) (mg/dL) (serum parameter);28 g/day textured soy flour;usual diet without soy;Non-Pharmacological;Measured;Chronic;Automatic;Down;2;18;18;48;26.5;18;18;26;28;43;28.5;0.557;NA;NA;Yes
2010;445;Effect of pioglitazone on systemic inflammation is independent of metabolic control and cardiac autonomic function in patients with type 2 diabetes.;http://www.ncbi.nlm.nih.gov/pubmed/19787290;Endocrinology & Metabolism;1;Body weight;No pioglitazone;Pioglitazone;Pharmacological;Measured;Chronic;Automatic;Down;2;18;18;9.2;11.9;18;18;11.6;11.4;NA;NA;NA;0.36;Exact;No
2010;451;Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention.;http://www.ncbi.nlm.nih.gov/pubmed/21353104;Pharmacology & Pharmacy;1;Total cholesterol (mg/dL);atorvastatin 5 mg;atorvastatin 20 mg;Pharmacological;Measured;Acute;Automatic;Down;2;15;15;36;25;15;15;28;32;NA;NA;NA;0.53;Exact;No
2010;454;Effects of casein phosphopeptide amorphous calcium fluoride phosphate paste on white spot lesions and dental plaque after orthodontic treatment: a 3-month follow-up;http://www.ncbi.nlm.nih.gov/pubmed/21083623;Dentistry, Oral Surgery & Medicine;1;Lesion depth (delta F (%));CPP-ACFP;Control;Non-Pharmacological;Measured;Acute;Automatic;Down;2;27;27;1.17;1.75;27;27;1.78;2.76;NA;NA;NA;NA;NA;No
2010;467;A pilot study examining the effectiveness of physical therapy as an adjunct to selective nerve root block in the treatment of lumbar radicular pain from disk herniation: a randomized controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/20864600;Orthopedics$ Rehabilitation;2;Low Back Pain Disability Questionnaire (DISQ);SNRB;SNRB + Physical Therapy;Non-Pharmacological;Scored;Acute;Assessed;Down;2;23;21;16.7;21.6;23;21;19.5;19.6;NA;NA;NA;0.83;Exact;No
2010;469;The effects of iron fortification on the gut microbiota in African children: a randomized controlled trial in Cote d'Ivoire.;http://www.ncbi.nlm.nih.gov/pubmed/20962160;Nutrition & Dietetics;1;Hemoglobin;nonfortified biscuits;iron-fortified biscuits;Non-Pharmacological;Measured;None;Automatic;Up;2;70;69;9.4;10.5;70;69;9.7;9.4;NA;NA;NA;NA;NA;No
2013;1;The Effectiveness of Group Therapy on the Family Functioning of Individuals under Methadone Treatment: A Clinical Trial.;http://www.ncbi.nlm.nih.gov/pubmed/24494151;NA;0;Family asessment device score;Group therapy was held based on the transtheoretical model of behavior change;Control;Non-Pharmacological;Scored;None;Assessed;Down;2;23;24;16.3;25.3;23;24;12;23.5;NA;NA;NA;0.08;Exact;No
2013;5;Ratio of leukotriene e(4) to exhaled nitric oxide and the therapeutic response in children with exercise-induced bronchoconstriction.;http://www.ncbi.nlm.nih.gov/pubmed/23277875;Allergy$ Immunology;2;Sputum LTE4;Montekulast ;fluticasone propionate (FP);Non-Pharmacological;Measured;Chronic;Automatic;Down;2;12;12;323.4;281.9;12;12;841.1;921.1;NA;NA;NA;0.018;Exact;Yes
2013;22;Chinese herbal medicine for impaired glucose tolerance: a randomized placebo controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/23672597;Integrative & Complementary Medicine;1;Fasting blood glucose (mmol/L);Jiangtang Xiaozhi;Placebo;Non-Pharmacological;Measured;Chronic;Automatic;Down;2;39;32;0.9;1;35;28;1.1;1.3;NA;NA;NA;0.7;Exact;No
2013;76;Effect of daily consumption of probiotic yoghurt on insulin resistance in pregnant women: a randomized controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/23187955;Nutrition & Dietetics;1;Fasting plasma glucose (FPG);conventional yogurt;probiotic yogurt;Non-Pharmacological;Measured;None;Automatic;Down;2;33;37;24.7;24.33;33;37;12.06;13.99;22.4;25.55;0.516;0.38;Exact;No
2013;78;Integrative TCM Conservative Therapy for Low Back Pain due to Lumbar Disc Herniation: A Randomized Controlled Clinical Trial.;http://www.ncbi.nlm.nih.gov/pubmed/23864883;Integrative & Complementary Medicine;1;Visual analogue scale (VAS);integrative TCM therapy;normal conservative treatment;Non-Pharmacological;Scored;Acute;Assessed;Down;2;306;102;19.6;19.61;297;99;2.29;6.76;18.55;17.21;0.568;0.001;Less than;Yes
2013;85;Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase iib randomized, controlled study.;http://www.ncbi.nlm.nih.gov/pubmed/23663752;Health Care Sciences & Services;1;Dermatology Life Quality Index;Apremilast BID 30 mg;Placebo;Pharmacological;Scored;Chronic;Assessed;Down;4;88;88;6.2;6.7;88;88;6.2;7.6;5.1;5.2;0.682;0.005;Exact;Yes
2013;95;Influencing self-rated health among adolescent girls with dance intervention: a randomized controlled trial;http://www.ncbi.nlm.nih.gov/pubmed/23403597;Pediatrics;1;Self-rated health;dance intervention group;Control group;Non-Pharmacological;Scored;None;Assessed;Up;2;59;53;0.88;0.73;50;50;0.7;0.57;0.94;0.61;0.525;0.38;Exact;No
2013;111;Unilateral repetitive transcranial magnetic stimulation of the motor cortex does not affect cognition in patients with fibromyalgia.;http://www.ncbi.nlm.nih.gov/pubmed/23079535;Psychiatry;1;RAVLT (Rey Auditory Verbal Learning Test) free recall;rTMS;Sham;Non-Pharmacological;Scored;Chronic;Automatic;Up;2;20;18;1.5;1.4;15;12;1.8;2.3;NA;NA;NA;NA;NA;No
2013;112;Mindfulness therapy for somatization disorder and functional somatic syndromes: randomized trial with one-year follow-up.;http://www.ncbi.nlm.nih.gov/pubmed/23272986;Psychiatry;1;SF-36 Physical Component;mindfulness therapy;enhanced treatment as usual;Non-Pharmacological;Scored;Chronic;Assessed;Up;2;57;60;9.8;9.4;45;45;10.6;9.5;NA;NA;NA;0.001;Exact;Yes
2013;113;Diet quality and weight change among overweight and obese postpartum women enrolled in a behavioral intervention program.;http://www.ncbi.nlm.nih.gov/pubmed/23146549;Nutrition & Dietetics;1;Total HEI-2005 score;Family- and home-based behavioral intervention;Control;Non-Pharmacological;Scored;Acute;Assessed;Up;2;131;145;11.2;11.8;131;145;11.1;11.9;NA;NA;NA;NA;NA;No
2013;127;Effects of Kivia powder on gut health in patients with occasional constipation: a randomized, double-blind, placebo-controlled study.;http://www.ncbi.nlm.nih.gov/pubmed/23758673;Nutrition & Dietetics;1;Bowel Movement Frequency;Kivia powder;Placebo;Non-Pharmacological;Measured;Acute;Automatic;Up;2;39;43;0.07;0.08;39;43;0.24;0.19;NA;NA;NA;0.02;Exact;Yes
2013;132;Nerve fiber layer thickness in eyes treated with red versus green laser in proliferative diabetic retinopathy: short-term results.;http://www.ncbi.nlm.nih.gov/pubmed/24080858;Ophthalmology;1;TSNIT average (RNFL thickness);red laser;green laser;Non-Pharmacological;Measured;Chronic;Automatic;Down;2;22;22;9.42;9.37;22;22;9.69;8.11;9.18;4.75;0.697;0.04;Exact;Yes
2013;138;Pentoxifylline, inflammation, and endothelial function in HIV-infected persons: a randomized, placebo-controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/23593327;Science & Technology - Other Topics;1;Flow-mediated dilation (FMD) of the brachial artery;PTX 400 mg orally thrice daily;Placebo;Pharmacological;Measured;Chronic;Automatic;Down;2;10;13;2.87;2.32;10;13;1.69;1.58;3.03;1.45;0.611;0.58;Exact;No
2013;150;A couple-based intervention for patients and caregivers facing end-stage cancer: outcomes of a randomized controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/21919119;Oncology$ Psychology$ Biomedical Social Sciences;3;Revised Dyadic Adjustment Scale;EFT;standard care;Non-Pharmacological;Scored;Chronic;Assessed;Up;2;22;20;4.8;7.6;22;18;4.6;10.3;NA;NA;NA;0.0001;Less than;Yes
2013;180;Motivational interviewing and problem solving treatment to reduce type 2 diabetes and cardiovascular disease risk in real life: a randomized controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/23597082;Nutrition & Dietetics$ Physiology;2;Diabetes risk according to the formula of the Atherosclerosis Risk In Communities (ARIC) Study;theory-based lifestyle intervention based on an innovative combination of motivational interviewing and problem solving treatment;existing health brochures;Non-Pharmacological;Measured;None;Assessed;Down;2;314;308;7.8;8.5;267;269;8.5;7.6;NA;NA;NA;NA;NA;No
2013;186;Feasibility of a psychosocial rehabilitation intervention to enhance the involvement of relatives in cancer rehabilitation: pilot study for a randomized controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/23821379;Health Care Sciences & Services;1;EORTC QLQ-C30 global health status;three ‘supportive talks’ and a residential rehabilitation course;Control;Non-Pharmacological;Scored;Chronic;Assessed;Up;2;19;21;24.69;24.08;6;13;12;20.79;NA;NA;NA;NA;NA;No
2013;188;Randomized controlled study of the antipyretic efficacy of oral paracetamol, intravenous paracetamol, and intramuscular diclofenac in patients presenting with fever to the emergency department.;http://www.ncbi.nlm.nih.gov/pubmed/24124372;Health Care Sciences & Services;1;Oral temperature at 90 minutes;1,000 mg oral paracetamol;75 mg intramuscular diclofenac;Pharmacological;Measured;Acute;Automatic;Down;3;145;150;0.47;0.44;142;143;0.54;0.41;0.51;0.43;0.464;0.0001;Less than;Yes
2013;200;Home blood pressure monitoring with nurse-led telephone support among patients with hypertension and a history of stroke: a community-based randomized controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/23128283;General & Internal Medicine;1;Systolic blood pressure;home blood pressure monitoring;usual care;Non-Pharmacological;Measured;Chronic;Automatic;Down;2;187;194;21.3;20.7;168;169;20.8;20.3;20.5;21.22;0.506;NA;NA;No
2013;204;Left dorsolateral prefrontal transcranial magnetic stimulation (TMS): sleep factor changes during treatment in patients with pharmacoresistant major depressive disorder.;http://www.ncbi.nlm.nih.gov/pubmed/23021320;Psychiatry;1;HAMD(Hamilton Ratin Scale for Depression) sleep factor score;active TMS;sham TMS;Non-Pharmacological;Scored;Acute;Assessed;Down;2;155;146;1.7;1.7;155;146;1.8;1.9;2;1.7;0.401;0.109;Exact;No
2013;206;Efficacy and safety of indomethacin 0.1% eye drops compared with ketorolac 0.5% eye drops in the management of ocular inflammation after cataract surgery.;http://www.ncbi.nlm.nih.gov/pubmed/22970738;Ophthalmology;1;Aqueous flare;indomethacin;ketorolac;Pharmacological;Measured;Acute;Automatic;Down;2;43;43;9.67;8.71;43;43;7.23;9.58;NA;NA;NA;0.013;Exact;Yes
2013;221;Full-mouth disinfection as a therapeutic protocol for type-2 diabetic subjects with chronic periodontitis: Twelve-month clinical outcomes. A randomized controlled clinical trial;http://www.ncbi.nlm.nih.gov/pubmed/23305133;Dentistry, Oral Surgery & Medicine;1;Clinical attachment level;full-mouth scaling and root planing (FMSRP) within 24 h + local application of CHX gel + CHX rinses for 60 days;FMSRP within 24 h + local application of Placebo gel + Placebo rinses for 60 days;Pharmacological;Measured;Chronic;Automatic;Up;2;19;18;0.85;0.99;19;18;0.9;0.81;NA;NA;NA;0.05;Less than;Yes
2013;244;Comparison between sitagliptin and nateglinide on postprandial lipid levels: The STANDARD study.;http://www.ncbi.nlm.nih.gov/pubmed/23493856;NA;0;AUC of Apo B48;sitagliptin (50 mg once daily);nateglinide (90 mg three times daily before meals);Pharmacological;Measured;Chronic;Automatic;Down;2;20;16;0.11;0.29;20;16;0.78;0.16;NA;NA;NA;0.019;Exact;Yes
2013;262;Randomized, Controlled Trial Evaluating a Baby Wash Product on Skin Barrier Function in Healthy, Term Neonates;http://www.ncbi.nlm.nih.gov/pubmed/23421327;Nursing$ Obstetrics & Gynecology;2;Transepidermal water loss at 14 days postbirth;bathing with a wash product;bathing with water alone;Non-Pharmacological;Measured;None;Automatic;Down;2;159;148;3.4;3.6;126;116;4.5;5.6;NA;NA;NA;0.89;Exact;No
2013;293;Community Diabetes Education (code) for uninsured Mexican Americans: a randomized controlled trial of a culturally tailored diabetes education and management program led by a community health worker.;http://www.ncbi.nlm.nih.gov/pubmed/23453178;Endocrinology & Metabolism;1;HbA1c;Community Diabetes Education (CoDE) program + usual medical care;usual medical care;Non-Pharmacological;Measured;Chronic;Automatic;Down;2;90;90;2.2;2.3;78;78;1.35;1.35;1.8;1.62;0.71;0.02;Exact;Yes
2013;309;Efficacy of psychosocial group intervention for children with chronic illness and their parents.;http://www.ncbi.nlm.nih.gov/pubmed/23478870;Pediatrics;1;Parent reported internalizing problems;Child intervention;Wait-List Control;Non-Pharmacological;Scored;Chronic;Assessed;Down;3;62;67;6;4.76;52;51;5.89;4.08;NA;NA;NA;0.008;Exact;Yes
2013;311;Acupuncture for chronic low back pain: a multicenter, randomized, patient-assessor blind, sham-controlled clinical trial.;http://www.ncbi.nlm.nih.gov/pubmed/23026870;Neurosciences & Neurology$ Orthopedics;2;VAS score for bothersomeness of cLBP;individualized real acupuncture treatments;sham acupuncture treatments;Non-Pharmacological;Scored;Chronic;Assessed;Down;2;57;59;1.5;1.14;57;59;2.44;1.84;NA;NA;NA;0.024;Exact;Yes
2013;340;Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study.;http://www.ncbi.nlm.nih.gov/pubmed/23288914;Cardiovascular System & Cardiology;1;Wall motion score index (WMSI);levosimendan;Placebo;Pharmacological;Scored;Acute;Assessed;Up;2;29;31;0.2;0.26;29;29;0.32;0.27;NA;NA;NA;0.031;Exact;Yes
2013;351;Effectiveness of multidisciplinary care for Parkinson's disease: a randomized, controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/23165981;Neurosciences & Neurology;1;Quality of life (Parkinson’s Disease Questionnaire: PDQ-39);care from a movement disorders specialist, PD nurses, and social worker;care from general neurologists;Non-Pharmacological;Scored;Chronic;Assessed;Down;2;51;49;14.4;12.4;51;49;14.2;13.4;5.8;8.6;0.853;0.02;Exact;Yes
2013;360;A randomized clinical trial of vitamin D supplementation in healthy adolescents.;http://www.ncbi.nlm.nih.gov/pubmed/23608721;Psychology$ Public, Environmental & Occupational Health$ Pediatrics;3;Serum 25OHD;200 IU of daily vitamin D3;1000 IU;Non-Pharmacological;Measured;None;Automatic;Up;2;25;29;6.2;7.3;25;29;7;6.6;6.3;6;0.594;0.87;Exact;No
2013;362;Effects of adjunctive metformin on metabolic traits in nondiabetic clozapine-treated patients with schizophrenia and the effect of metformin discontinuation on body weight: a 24-week, randomized, double-blind, placebo-controlled study.;http://www.ncbi.nlm.nih.gov/pubmed/23759461;Psychology$ Psychiatry;2;Body weight;Metformin;Placebo;Pharmacological;Measured;Chronic;Automatic;Down;2;28;27;13.7;9.6;28;27;12.6;8.7;NA;NA;NA;0.85;Exact;No
2013;426;The effect of aerobic exercise on metabolic and inflammatory markers in breast cancer survivors--a pilot study.;http://www.ncbi.nlm.nih.gov/pubmed/23430010;Oncology$ Health Care Sciences & Services$ Rehabilitation;3;Waist circumference;8-week moderate-intensity aerobic exercise group;Usual care;Non-Pharmacological;Measured;Chronic;Automatic;Down;2;16;10;11.9;8.9;16;10;12.2;12.3;2.65;2.58;0.971;0.45;Exact;No
2013;431;Consumption of yogurts fortified in vitamin D and calcium reduces serum parathyroid hormone and markers of bone resorption: a double-blind randomized controlled trial in institutionalized elderly women.;http://www.ncbi.nlm.nih.gov/pubmed/23653431;Endocrinology & Metabolism;1;Serum 25OHD;Calcium-fortified yogurt (FY);Nonfortified control yogurt (CY);Non-Pharmacological;Measured;None;Automatic;Up;2;31;27;6.68;3.12;29;27;13.46;14.03;NA;NA;NA;0.0001;Less than;Yes
2013;432;PTSD symptom reduction with mindfulness-based stretching and deep breathing exercise: randomized controlled clinical trial of efficacy.;http://www.ncbi.nlm.nih.gov/pubmed/23720785;Endocrinology & Metabolism;1;PCL-C total;mindfulness-based stretching and deep breathing exercise (MBX);Control;Non-Pharmacological;Measured;None;Assessed;Down;2;11;11;11.2;12.7;11;11;3.3;16.3;12.01;13.37;0.437;0.85;Exact;No
2013;448;Effects of antihypertensive drugs on central blood pressure in humans: a preliminary observation.;http://www.ncbi.nlm.nih.gov/pubmed/23736112;Cardiovascular System & Cardiology;1;Heart rate;Amlodipine;Placebo;Pharmacological;Measured;Chronic;Automatic;Down;4;33;35;15;10;33;35;12;9;9;10;0.717358491;0.58;Exact;No
2013;450;Efficacy and Safety of Metronidazole for Pulmonary Multidrug-Resistant Tuberculosis;http://www.ncbi.nlm.nih.gov/pubmed/23733467;Microbiology$ Pharmacology & Pharmacy;2;Mean lung lesions composite score;metronidazole;Placebo;Pharmacological;Scored;Acute;Assessed;Down;2;15;16;5.03;4;15;16;3.87;3.6;NA;NA;NA;NA;NA;No
2013;452;Progesterone therapy increases free thyroxine levels-data from a randomized placebo-controlled 12-week hot flush trial;http://www.ncbi.nlm.nih.gov/pubmed/23252963;Endocrinology & Metabolism;1;Thyroid stimulating hormone (TSH, mU/l),;progesterone;Placebo;Pharmacological;Measured;None;Automatic;Down;2;39;30;0.9;1;39;29;0.64;1.37;0.29;0.75;0.84;0.06;Exact;No
2013;480;A home-based intervention to reduce depressive symptoms and improve quality of life in older African Americans: a randomized trial.;http://www.ncbi.nlm.nih.gov/pubmed/24026257;General & Internal Medicine;1;Patient Health Questionnaire-9 (PHQ-9);home-based intervention delivered by social workers;Wait-List Control;Non-Pharmacological;Scored;Acute;Assessed;Down;2;106;102;5.15;5.05;106;102;6.18;6.06;6.18;6.06;0.28;0.001;Exact;Yes
2013;485;Bevacizumab in age-related macular degeneration: a randomized controlled trial on the effect of injections every 4 weeks, 6 weeks and 8 weeks;http://www.ncbi.nlm.nih.gov/pubmed/23773796;Ophthalmology;1;Visual acuity;Bevacizumab every 6 weeks;Bevacizumab every 4 weeks;Pharmacological;Measured;Chronic;Automatic;Up;3;63;64;13;12;57;46;17.6;16.3;10.98;13.7;0.518958991;0.88;Exact;No
2013;488;Clinical and microbiological changes after minimally invasive therapeutic approaches in intrabony defects: a 12-month follow-up;http://www.ncbi.nlm.nih.gov/pubmed/23053707;Dentistry, Oral Surgery & Medicine;1;Relative clinical attachment level;minimally invasive surgical technique (MIST).;minimally invasive nonsurgical technique (MINST);Non-Pharmacological;Measured;Acute;Automatic;Up;2;14;13;1.56;2.11;14;13;1.52;1.79;1.14;1.13;0.811;NA;NA;No
2013;492;Safety of intravenous ivabradine in acute ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention: a randomized, placebo-controlled, double-blind, pilot study.;http://www.ncbi.nlm.nih.gov/pubmed/24222839;NA;0;Heart rate;Ivabradine;Placebo;Pharmacological;Measured;Acute;Automatic;Down;2;81;40;9.8;8.1;81;40;10.1;14.6;11.7;12.02;0.19;0.001;Less than;Yes
2013;495;Introducing reproductive life plan-based information in contraceptive counselling: an RCT;http://www.ncbi.nlm.nih.gov/pubmed/23842564;Obstetrics & Gynecology$ Reproductive Biology;2;Total score of knowledge;oral and written RLP-based information about reproduction + contraceptive counselling, Chlamydia testing, cervical screening;contraceptive counselling, Chlamydia testing, cervical screening;Non-Pharmacological;Scored;None;Automatic;Up;3;101;100;2.9;2.6;89;85;2.8;2.5;NA;NA;NA;0.001;Less than;Yes
2013;496;The Effects of Panax Ginseng on Lipid Profile, Pro-oxidant: Antioxidant Status and High-sensitivity C Reactive Protein Levels in Hyperlipidemic Patients in Iran.;http://www.ncbi.nlm.nih.gov/pubmed/24130946;NA;0;Serum TC level;Ginseng;Placebo;Non-Pharmacological;Measured;Chronic;Automatic;Down;2;18;18;44.41;48;18;18;25.9;36.02;NA;NA;NA;NA;NA;No
2013;552;The effect of low glycemic index diet on body weight status and blood pressure in overweight adolescent girls: a randomized clinical trial.;http://www.ncbi.nlm.nih.gov/pubmed/24133618;Nutrition & Dietetics;1;Body weight;Low glycemic Index Group;Healthy nutrition recommendations Group;Non-Pharmacological;Measured;Acute;Automatic;Down;2;19;22;9.72;16.32;19;22;8.85;15.9;NA;NA;NA;0.0001;Exact;Yes
2013;562;Effect of I-f-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.;http://www.ncbi.nlm.nih.gov/pubmed/23916925;Cardiovascular System & Cardiology;1;Post-exercise LV filling pressure (E/e');Ivabradine;Placebo;Pharmacological;Measured;Acute;Automatic;Up;2;30;31;3.2;3.1;30;31;3;3.3;NA;NA;NA;0.001;Exact;Yes
2013;569;Evaluation of an ICF-based patient education programme for stroke patients: a randomized, single-blinded, controlled, multicentre trial of the effects on self-efficacy, life satisfaction and functioning.;http://www.ncbi.nlm.nih.gov/pubmed/23252844;Psychology;1;Liverpool Self-Efficacy Scale;ICF-based patient education programme;attention-Placebo CG;Non-Pharmacological;Scored;Acute;Assessed;Up;2;110;102;4.69;5.06;110;102;6.03;6.06;NA;NA;NA;0.01;Less than;Yes
2013;571;The YOU CALL-WE CALL randomized clinical trial: Impact of a multimodal support intervention after a mild stroke.;http://www.ncbi.nlm.nih.gov/pubmed/24221841;Cardiovascular System & Cardiology;1;Visual analogue scale (VAS);YOU CALL (participant can contact a resource person);WE CALL (study initiated phone support/information provision);Non-Pharmacological;Scored;Acute;Assessed;Down;2;94;92;20.4;18.7;77;72;15.8;14.3;NA;NA;NA;0.27;Exact;No
2013;573;Efficacy of periosteal stimulation for chronic pain associated with advanced knee osteoarthritis: a randomized, controlled clinical trial.;http://www.ncbi.nlm.nih.gov/pubmed/24184053;Pharmacology & Pharmacy;1;WOMAC pain index (collected on each knee);periosteal stimulation therapy;Control;Non-Pharmacological;Scored;Chronic;Assessed;Down;3;108;104;3.3;3.4;96;99;4.2;4.4;NA;NA;NA;0.0683;Exact;No
2013;586;The efficacy of acyclovir in treatment of the pemphigus vulgaris.;http://www.ncbi.nlm.nih.gov/pubmed/24523784;General & Internal Medicine;1;Pemphigus severity score;Acyclovir;Control;Pharmacological;Scored;Chronic;Assessed;Down;2;15;15;1.4;1.6;15;15;0.6;0.73;NA;NA;NA;NA;NA;No
2013;601;Renal safety and angiotensin II blockade medications in patients undergoing non-emergent coronary angiography: a randomized controlled study.;http://www.ncbi.nlm.nih.gov/pubmed/24511648;General & Internal Medicine;1;Glomerular Filtration Rate - GFR;ACE/ARB stopped 24 hours prior to the procedure and restarted immediately after the procedure;ACE/ARB continued throughout the study period;Pharmacological;Measured;Acute;Automatic;Up;3;30;33;30.53;22.4;30;33;28.85;25.78;10.37;11.04;0.919;0.85;Exact;No
2013;628;A caregiver educational program improves quality of life and burden for cancer patients and their caregivers: a randomised clinical trial.;http://www.ncbi.nlm.nih.gov/pubmed/23759361;Oncology$ Nursing;2;QoL by patient (SF36, physical functioning);educational programme performed by nurses to improve their skills in meal support, nursing care, welfare care, or symptom management;Control;Pharmacological;Scored;Chronic;Assessed;Up;2;33;34;29.6;29.6;33;34;35.8;30.3;NA;NA;NA;0.27;Exact;No
2013;629;Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/23993887;Obstetrics & Gynecology$ Reproductive Biology;2;Antimüllerian hormone;Salpingectomy;No salpingectomy;Non-Pharmacological;Measured;Acute;Automatic;Down;2;15;15;2.72;2.57;15;15;1.99;3.12;0.9;1.45;0.896;0.97;Exact;No
2013;630;The effect of beta-alanine supplementation on isokinetic force and cycling performance in highly trained cyclists.;http://www.ncbi.nlm.nih.gov/pubmed/23630052;Nutrition & Dietetics$ Sport Sciences;2;Four-Minute Cycling Time-Trial Average Power;Beta-Alanine;Placebo;Non-Pharmacological;Measured;None;Automatic;Up;2;8;8;43;48;8;8;43;47;7.3;9.7;0.982;0.25;Exact;No
2013;635;The effects of green tea consumption on metabolic and anthropometric indices in patients with Type 2 diabetes.;http://www.ncbi.nlm.nih.gov/pubmed/24523800;General & Internal Medicine;1;Body weight;four cups of green tea per day;Control;Non-Pharmacological;Measured;Chronic;Automatic;Down;3;24;14;9.26;8.2;24;14;9.42;9.44;NA;NA;NA;0.794;Exact;No
2013;640;Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial.;http://www.ncbi.nlm.nih.gov/pubmed/23821414;Pediatrics$ Pharmacology & Pharmacy;2;ABC-C irritability subscale score;Riluzole + risperidone;Placebo + risperidone;Pharmacological;Scored;Chronic;Assessed;Down;2;20;20;4.18;9.98;20;20;5.57;7.86;NA;NA;NA;0.13;Exact;No
2013;641;Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases;http://www.ncbi.nlm.nih.gov/pubmed/23917308;Oncology$ Urology & Nephrology;2;Leg extension 1RM;12-week resistance exercise program in which exercise prescription was based on the location of bone lesions;usual care;Non-Pharmacological;Measured;Chronic;Assessed;Up;2;10;10;17.6;23.5;10;10;16.7;21.4;NA;NA;NA;0.016;Exact;Yes
2013;645;Acupuncture for infantile colic: a blinding-validated, randomized controlled multicentre trial in general practice.;http://www.ncbi.nlm.nih.gov/pubmed/24228748;Health Care Sciences & Services$ General & Internal Medicine;2;Crying time;acupuncture;Control;Non-Pharmacological;Measured;Acute;Automatic;Down;2;38;41;78.63;94.74;37;40;105.52;93.58;NA;NA;NA;0.482;Exact;No
2013;654;Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial.;http://www.ncbi.nlm.nih.gov/pubmed/24067488;General & Internal Medicine;1;Bowel subset score (IBDQ-B);Gastroenterologist group;Booklet group;Non-Pharmacological;Scored;Acute;Assessed;Up;3;70;68;10.8;12.9;59;57;8.4;12.9;10.3;13.2;0.505638502;0.03;Exact;Yes
2013;655;High-dose atorvastatin reduces periodontal inflammation: a novel pleiotropic effect of statins.;http://www.ncbi.nlm.nih.gov/pubmed/24070911;Cardiovascular System & Cardiology;1;FDG uptake (TBR);Atorvastatin 10 mg;Atorvastatin 80 mg;Pharmacological;Measured;Acute;Automatic;Down;2;29;30;1.07;1.43;29;30;1.32;1.29;0.71;0.87;0.802;0.04;Exact;Yes
2013;656;Arthroscopic partial meniscectomy versus sham surgery for a degenerative meniscal tear.;http://www.ncbi.nlm.nih.gov/pubmed/24369076;General & Internal Medicine;1;Lysholm Knee Score;Partial Meniscectomy;Sham Surgery;Non-Pharmacological;Scored;Chronic;Assessed;Up;2;70;76;14.7;14.6;70;76;15.79;13.79;17.5;17.35;0.293;NA;NA;No
